Détails sur le projet
Description
Currently singular vaccines against either PRRSV or PCV2 are available but a bi-valent vaccine against both PRRSV and PCV2 are lacking. The objective of this project is to evaluate the use of non-pahtogenic PCV1 and the vaccine virus PCV1-2 as potential vaccine delivery vectors for the development of a bi-valent vaccine against both PRRSV and PCV2. We expect that the project will validate the use of PCV1 as a useful vaccine delivery vector for other swien pathogens, and we also expect that we will demonstarte that the vaccine virus PCV1-2 can serve as a vaccine delivery vector for creating bi-valent vaccines against other swine viruses.
Statut | Terminé |
---|---|
Date de début/de fin réelle | 7/15/10 → 9/30/19 |
Financement
- National Science Foundation: 269 999,00 $ US
Keywords
- Ingeniería eléctrica y electrónica
- Ciencia de los materiales (todo)
- Inmunología
- Virología
- Neumología
- Agronomía y cultivos
- Alimentación
Empreinte numérique
Explorer les sujets de recherche abordés dans ce projet. Ces étiquettes sont créées en fonction des prix/bourses sous-jacents. Ensemble, ils forment une empreinte numérique unique.